Literature DB >> 11039415

Results of macular hole surgery in patients over 80 years of age.

J T Thompson, R N Sjaarda.   

Abstract

PURPOSE: To evaluate the results of macular hole surgery in patients over 80 years of age to determine if surgery is beneficial in an elderly patient population.
METHODS: Twenty consecutive patients over age 80 with idiopathic macular holes and 20 nonconsecutive controls younger than 80 years treated for idiopathic macular holes were compared in a retrospective, consecutive case-control series.
RESULTS: The macular hole was closed 3 months after surgery in 19/20 eyes (95%) of patients over age 80 years and 17/20 eyes (85%) of patients under 80 years. The mean preoperative visual acuity was 20/160 in patients over 80 years and 20/160-1 in patients under 80 years. The mean visual acuity at 3 months was 20/63 in eyes of patients over 80 years and 20/80 in eyes of patients under 80 years (P = 0.3). The mean visual acuity was 20/50-2 in eyes of patients over 80 years and 20/63-2 in eyes of patients under 80 years at the final examination (P = 0.403).
CONCLUSIONS: Macular hole surgery is beneficial in patients over 80 years of age, with very similar results to those of patients younger than 80 years of age. Age should not be the primary criterion for recommending macular hole surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039415     DOI: 10.1097/00006982-200009000-00001

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

1.  Results of vitrectomy and the no-touch-technique using autologous adjuvants in macular hole treatment.

Authors:  H Hoerauf; H Klüter; E Joachimmeyer; J Roider; C Framme; P Schlenke; H Kirchner; H Lagua
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 2.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

Review 3.  Fourth time lucky: a case of multiple recurrence of a macular hole.

Authors:  H M Hussin; R H Y Asaria; N E Knox Cartwright; R H B Grey
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.